David Brenner, MD
I studied medicine at the Ruprecht-Karls-Universität Heidelberg. In my MD thesis in Prof. Dr. Ana Martina-Villalba’s Iab at the DKFZ Heidelberg I examined the pathogenic role of the CD95 system in circulating myeloid cells in a mouse model for Parkinson’s disease. I obtained my postdoctoral training at Prof. Dr. Jochen Weishaupt’s lab in Ulm and Mannheim. During this period I contributed to the identification and characterization, respectively, of the ALS genes NEK1, KIF5A, and TBK1. I completed my neurological specialization at the university hospital of Ulm headed by Prof. Dr. Albert Ludolph. In 2021 I was appointed senior physician. In 2022 I obtained the qualification for professorship and started my own lab at Ulm University. My clinical and scientific focus is on the genetics of neurodegenerative diseases. In cooperation with intra- and extramural partners we employ phenotyping of patient cohorts and disease modeling in vitro and in vivo models combined with use of multi-omic analyis.